Skip to main content
Opens in new window
NHS Wales
NHS 111 Wales
Skip Navigation
Accessibility
Contact us
Cymraeg
Cymraeg
All...
Search
All Wales Therapeutics and Toxicology Centre
Search
Cymraeg
Cymraeg
Menu
Home
Accessing medicines
Show Submenu For Accessing medicines
Medicine recommendations
Access to medicines in Wales
Make a submission
Medicines optimisation and safety
Show Submenu For Medicines optimisation and safety
Medicines optimisation guidance, resources and data
Yellow Card Centre Wales
Welsh National Poisons Unit
Sodium valproate information hub
Work in progress
News, meetings and events
Show Submenu For News, meetings and events
News
Meetings
Events
About us
Show Submenu For About us
Who we are
What we do
Our committees
Who we work with
Our research
Our reports and strategies
Sustainability
Contact us
More
×
ID4031: Durvalumab with gemcitabine and cisplatin for treating unresectable or advanced biliary tract cancer
NHS Wales
NHS 111 Wales
Accessibility
Contact us
All...
Search
Listen
Home
›
Links
Links
15/11/2023
ID4031: Durvalumab with gemcitabine and cisplatin for treating unresectable or advanced biliary tract cancer
27/04/2023
Assessments in progress
15/07/2022
Image links
08/01/2022
Homepage block
07/01/2022
Appraisals in progress (3)
07/01/2022
standalones
08/11/2021
Appraisals in progress
08/11/2021
Appraisals in progress (1)
12/07/2021
WNPU
08/07/2021
YCC Wales useful links
28/06/2021
homepage links
28/06/2021
YCC Wales social links
25/06/2021
YCC Wales contact email
18/06/2021
Latest One Wales decisions
22/01/2021
NICE Antimicrobial Health Technology Evaluation
14/08/2020
One Wales
01/06/2020
Welsh Government
16/03/2020
Medication charts and records
26/02/2020
NICE HSTs
26/02/2020
NICE IDs
1
2
Follow AWTTC: